BASi (BASI) Names Jeffrey Potrzebowski CFO And James Bourdage VP Bioanalytical Operations

BASi (BASI) Names Jeffrey Potrzebowski CFO And James Bourdage VP Bioanalytical Operations

Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced the appointment of Jeffrey Potrzebowski as Chief Financial Officer and James S. Bourdage, Ph.D., as Vice President Bioanalytical Operations.

BASi President & CEO Jacqueline Lemke said, "These appointments represent significant steps forward in our continuing program to build a management team with the depth, experience and dedication to take BASi to the next level and achieve our goals for growth and profitability. 

Suggested Articles

J&J plans to have a vaccine in the clinic by September and win emergency use authorization early next year.

The biotech is pausing enrollment in some infectious and rare disease trials while continuing to try to add patients to its cancer studies.

Back in 2012, Aveo announced that its second most advanced asset, ficlatuzumab, had flopped in a midstage cancer test; for years, we heard nothing.